These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 8465453)
21. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550 [TBL] [Abstract][Full Text] [Related]
22. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Mitri GM; Lucas M; Fertig N; Steen VD; Medsger TA Arthritis Rheum; 2003 Jan; 48(1):203-9. PubMed ID: 12528120 [TBL] [Abstract][Full Text] [Related]
23. Scl-86, a marker antigen for diffuse scleroderma. van Venrooij WJ; Stapel SO; Houben H; Habets WJ; Kallenberg CG; Penner E; van de Putte LB J Clin Invest; 1985 Mar; 75(3):1053-60. PubMed ID: 3980727 [TBL] [Abstract][Full Text] [Related]
24. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies. Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786 [TBL] [Abstract][Full Text] [Related]
25. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma]. Johanet C; Agostini MM; Vayssairat M; Abuaf N Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207 [TBL] [Abstract][Full Text] [Related]
27. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma. Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149 [TBL] [Abstract][Full Text] [Related]
28. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients. García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145 [TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of anti-nucleolar antibodies detected by immunoprecipitation method in patients with systemic sclerosis]. Kuwana M; Mimori T; Hama N; Kaburaki J; Okano T; Tojo T Ryumachi; 1992 Feb; 32(1):39-46. PubMed ID: 1604415 [TBL] [Abstract][Full Text] [Related]
30. Autoantibodies against calpastatin in sera from patients with systemic sclerosis. Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655 [TBL] [Abstract][Full Text] [Related]
31. [Progress in laboratory tests of connective tissue diseases]. Yamane K; Kato S; Sakauchi M Rinsho Byori; 1989 Dec; 37(12):1311-6. PubMed ID: 2614963 [TBL] [Abstract][Full Text] [Related]
32. [Scleroderma--systemic sclerosis. Serology, lung function and survival]. Ullman S; Halberg P; Wiik A; Jacobsen S Ugeskr Laeger; 1999 May; 161(21):3084-90. PubMed ID: 10377851 [TBL] [Abstract][Full Text] [Related]
33. Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies. Spencer-Green G; Alter D; Welch HG Am J Med; 1997 Sep; 103(3):242-8. PubMed ID: 9316557 [TBL] [Abstract][Full Text] [Related]
34. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody. Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458 [TBL] [Abstract][Full Text] [Related]
35. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features. Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838 [TBL] [Abstract][Full Text] [Related]
36. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238 [TBL] [Abstract][Full Text] [Related]
37. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. Ulanet DB; Wigley FM; Gelber AC; Rosen A Arthritis Rheum; 2003 Feb; 49(1):85-92. PubMed ID: 12579598 [TBL] [Abstract][Full Text] [Related]
38. Autoantibodies in scleroderma. Pollard KM; Reimer G; Tan EM Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161 [TBL] [Abstract][Full Text] [Related]
39. [Anti-Scl-70 antibody and anti-nucleolar antibody in patients with systemic sclerosis]. Kinoshita M Nihon Rinsho; 1990 Feb; 48 Suppl():494-6. PubMed ID: 2355569 [No Abstract] [Full Text] [Related]
40. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)]. Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]